slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 30,301-30,330
Pages 1,379
Rows per page 30
Component
30,301-30,330 of 41,369
17
The slide highlights inorganic growth strategy through M&A.Azerion | Investor Presentation Deck | 25 slides · Azerion
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
08
The slide uses a process flow diagram to illustrate the business model.BenevolentAI | Investor Presentation Deck | 19 slides · BenevolentAI
Pitch deck Investor relations Beat · Business ModelLoop · Cost Of Inaction1 hit
09
The chart uses a Gantt-style visualization to show progress from Target ID to Commercial stages.BenevolentAI | Investor Presentation Deck | 19 slides · BenevolentAI
Pitch deck Investor relations Beat · Pipeline depth and progressionLoop · Cost Of Inaction1 hit
10
The slide uses a split-layout: left side defines the disease burden and market, right side defines the drug mechanism.BenevolentAI | Investor Presentation Deck | 19 slides · BenevolentAI
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses a process diagram to show the transition from Part A to Part B.BenevolentAI | Investor Presentation Deck | 19 slides · BenevolentAI
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
13
Includes a breakdown of UC severity levels (64%, 31%, 5%) and a summary of the drug's mechanism and target patient population.BenevolentAI | Investor Presentation Deck | 19 slides · BenevolentAI
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
The chart compares actual/projected pipeline growth against an 'Industry Standard' benchmark line.BenevolentAI | Investor Presentation Deck | 19 slides · BenevolentAI
Pitch deck Investor relations 1 hit
03
Bigbear AI | Investor Conference Presentation Deck | 21 slidesBigbear AI | Investor Conference Presentation Deck | 21 slides · BigBear.ai
Conference presentation Investor relations 1 hit
05
Uses a metaphor to frame the value proposition of the software.Bigbear AI | Investor Conference Presentation Deck | 21 slides · BigBear.ai
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
03
Bigbear AI | Investor Presentation Deck | 21 slidesBigbear AI | Investor Presentation Deck | 21 slides · BigBear.ai
Pitch deck Investor relations 1 hit
05
Uses a common consumer technology (Google Maps) to demystify complex enterprise AI decision-making.Bigbear AI | Investor Presentation Deck | 21 slides · BigBear.ai
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
The slide uses a proprietary three-stage framework (Observe, Orient, Dominate) to categorize their product offerings.Bigbear AI | Investor Presentation Deck | 21 slides · BigBear.ai
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses a tree-like structure to map study arms to specific patient cohorts and their corresponding interim outcomes.BioAtla | Investor Conference Presentation Deck | 15 slides · BioAtla
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide highlights the first-in-class potential of the CAB-ROR2-ADC therapy.BioAtla | Investor Conference Presentation Deck | 15 slides · BioAtla
Conference presentation Investor relations 1 hit
06
The slide combines a bar chart for revenue projections and a segmented pie/fan chart for patient population sizing.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
Includes a list of key metrics and a bottom banner highlighting broader societal impact.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Problem StatementLoop · Logic Chain1 hit
22
The slide highlights step 2 (Mapping of mutations) and provides a visual representation of DNA sequencing comparing normal and cancer cells.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
26
The chart uses a broken y-axis to show high-frequency outliers alongside the long tail of low-frequency targets.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
31
The slide uses a combination of microscopy images and a line chart to demonstrate efficacy.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
35
Includes chemical structure of PSAR-LNP components and a line chart comparing in vivo expression profiles.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
38
The slide uses a 5-step process diagram to illustrate the workflow, with a specific focus on step 3 (Neoantigen prediction) being powered by AI/ML.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
42
The ROC curve shows the new model (blue) consistently outperforming the baseline NetMHCpan 4.1 EL (orange).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
43
The slide illustrates a multi-stage computational pipeline (Structural modeling -> EWS score -> ML modeling) and compares detection timing against WHO designations.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
49
The slide uses a map-based visualization to communicate operational scale and geographic reach.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
63
FIH stands for first-in-human.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
64
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
67
The table highlights that all tested Omicron-modified vaccines met the superiority criterion (lower bound of 95% CI for GMR > 1.0).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
68
The table highlights that all tested Omicron-modified vaccines met the super superiority criterion (GMR lower bound > 1.5).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
77
Data shows neutralization titers for OMI and Bivalent vaccines against BA.1 and BA.4/5 variants.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
80
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit